These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ablation of primary afferent neurons by neonatal capsaicin treatment reduces the susceptibility of the portal hypertensive gastric mucosa to ethanol-induced injury in cirrhotic rats. Camara PR; Ferraz GJ; Franco-Penteado CF; Sbragia-Neto L; Meirelles LR; Teixeira SA; Muscara MN; Velloso LA; Antunes E; Ferraz JG Eur J Pharmacol; 2008 Jul; 589(1-3):245-50. PubMed ID: 18555214 [TBL] [Abstract][Full Text] [Related]
4. Changes in gastric mucosal microcirculation and mucosal lesions in portal hypertensive rats. Nishida H; Kodama T; Satoh T; Fuse Y; Yamashita S J Gastroenterol Hepatol; 1989; 4 Suppl 1():88-90. PubMed ID: 2519097 [No Abstract] [Full Text] [Related]
5. Progressive hepatocytic fatty infiltration in rats with prehepatic portal hypertension. Alonso MJ; Aller MA; Corcuera MT; Nava MP; Gömez F; Angulo A; Arias J Hepatogastroenterology; 2005; 52(62):541-6. PubMed ID: 15816474 [TBL] [Abstract][Full Text] [Related]
6. The effect of prostacyclin on the gastric mucosa in portal-hypertensive rats. Kishihara F; Hashizume M; Ohta M; Kawanaka H; Tomikawa M; Higashi H; Tanoue K; Sugimachi K Hepatogastroenterology; 2002; 49(43):279-84. PubMed ID: 11941975 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats. Fernandez M; Mejias M; Angermayr B; Garcia-Pagan JC; Rodés J; Bosch J J Hepatol; 2005 Jul; 43(1):98-103. PubMed ID: 15893841 [TBL] [Abstract][Full Text] [Related]
8. [Circulation in liver cirrhosis patients and the principles for correcting portal hypertension]. Patsiora MD; Ershov IuA Khirurgiia (Mosk); 1973 May; 49(5):72-9. PubMed ID: 4795477 [No Abstract] [Full Text] [Related]
12. The dilemma of shunt surgery. McDermott WV Major Probl Clin Surg; 1974; 14():267-77. PubMed ID: 4590027 [No Abstract] [Full Text] [Related]
13. Unlocking the mysteries of portal hypertensive gastropathy. O'Brien MD; Gostout CJ Am J Gastroenterol; 1993 Sep; 88(9):1456-8. PubMed ID: 8362852 [No Abstract] [Full Text] [Related]
14. Involvement of nitric oxide and prostaglandins in gastric mucosal hyperemia of portal-hypertensive anesthetized rats. Casadevall M; Panés J; Piqué JM; Marroni N; Bosch J; Whittle BJ Hepatology; 1993 Sep; 18(3):628-34. PubMed ID: 8359804 [TBL] [Abstract][Full Text] [Related]
15. Hemorrhage from a portal-systemic venous shunt with unusual localization in a case of portal hypertension. Börjesson B; Olsson AM; Vang JO Scand J Gastroenterol; 1974; 9(6):571-3. PubMed ID: 4547595 [No Abstract] [Full Text] [Related]
16. The gastric mucosa in portal hypertension: effects of topical bile acid. Sarfeh IJ; Tarnawski A; Maeda R; Raymont K; Mason GR; Ivey KJ Scand J Gastroenterol Suppl; 1984; 92():189-94. PubMed ID: 6588511 [TBL] [Abstract][Full Text] [Related]
17. Significance of hemodynamic studies in the evaluation of portal hypertension. Smith GW Am Surg; 1973 Jan; 39(1):40-7. PubMed ID: 4686134 [No Abstract] [Full Text] [Related]
18. Molecular mechanisms of increased intrahepatic resistance in portal hypertension. Shah V J Clin Gastroenterol; 2007; 41 Suppl 3():S259-61. PubMed ID: 17975474 [TBL] [Abstract][Full Text] [Related]